加科思高管逆势增持近亿港元 KRAS与iADC潜力凸显

新浪财经
Sep 26, 2025

来源:智通财经网在港股18A医药股多家公司高管减持的背景下,加科思药业(01167)近日公告称,公司董事长兼首席执行官王印祥博士及一致行动人斥资近1亿港元增持公司股份,合计买入逾1105万股。与此同时,公司此前公布的1亿港元回购计划也已启动,目前执行约267万港元,未来一年预计将持续推进。公司公告称,此次一致行动人增持与公司回购是出于对公司长期发展的坚定信心。市场人士认为,高管在高位逆势增持的举措...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10